FDA
-
-
-
-
-
-
-
Edwards Lifesciences (EW) PT Raised to $105 at Stifel: Well-Positioned for 2026
-
-
-
-
-
-
-
Picard Medical adds two board members following IPO
-
-
-
-
-
-
-
JPMorgan on Boston Scientific (BSX): 'We’d be buyers of BSX on any material weakness'
-
-
-
-
-
-
-
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
-
-
-
-
-
-
-
Edwards Lifesciences (EW) Outlines Growth Strategy
-
-
-
-
-
-
-
Edwards Lifesciences Reports Fourth Quarter Results
-
-
-
-
-
-
-
TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION
-
322,096 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

